Contact this trialFirst, we need to learn more about you.
Vaccines Immune Response with Ozanimod for Multiple Sclerosis
Recruiting2 awardsPhase 3
Patchogue, New York
This trial will compare the safety and effectiveness of a new MS drug, ozanimod, to interferon-beta and no disease modifying therapies. The data from this study will be used to support the labels for ozanimod in MS.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.